InsideHer Learning · Clinician Course

Clinical management pathways for endometriosis

A clinician-facing course on consult sequencing, medical treatment, referral thresholds, surgery, fertility-priority care, and multidisciplinary support through April 2026.

Start the course Return to all endometriosis courses

7: course modules
4: quick pathways
April 2026: guidance current to

✦

Course overview

Use symptom pattern, fertility priorities, and disease complexity to choose the next management step deliberately.

This course is written for clinicians and allied teams who need a practical framework for initial medical management, imaging and diagnostic escalation, specialist referral, surgical decision-making, postoperative planning, and persistent-pain support.

Treatment sequencing

What this course separates

Separates pain control, hormonal suppression, surgery, and fertility pathways clearly so each step is matched to the dominant problem.

Referral logic

What it keeps visible

Keeps specialist referral thresholds visible when deep disease is possible, and frames surgery as goal-specific rather than automatic escalation.

Practice ready

What it protects

Protects shared decision-making when evidence is mixed or tradeoffs are substantial, building a review plan instead of a one-off treatment offer.

Clinician course

Working principles

Match the step to the dominant problem. Use shared decision-making when options are preference-sensitive. Escalate early when deep disease or organ involvement is plausible.

Quick start: early pain-dominant consult

Start with Modules 2 and 7 when the main job is first-line medical management, symptom relief, and setting a review plan before over-escalating. Send: Endometriosis Treatment Options.

Quick start: possible deep disease or anatomy concern

Start with Modules 3 and 4 when bowel, bladder, ureter, deep dyspareunia, imaging findings, or prior treatment failure suggest the need for specialist surgical framing. Send: Symptom Tracking and Appointment Prep.

Quick start: fertility-priority consult

Start with Modules 5 and 7 when conception timing, ovarian reserve, endometrioma, ART planning, or prior surgery change the treatment logic. Send: Endometriosis Treatment Options.

Quick start: persistent pain despite prior treatment

Start with Modules 6 and 7 when recurrent flares, central sensitization concerns, pelvic floor dysfunction, repeated medication changes, or post-surgical pain persistence dominate. Send: Endometriosis Pain Flare Guide.

Clinical shortcut

If fertility is the priority, the management ladder changes

Avoid defaulting to stronger suppressive therapy when the real decision is whether to move toward fertility assessment, ART, or a carefully selected surgical step.

Module 1

First Consult Framing

The initial clinical task is to identify the dominant problem, not simply confirm that pelvic pain exists. The treatment conversation changes when the burden is driven by cyclical pain, heavy bleeding, bowel symptoms, urinary symptoms, deep dyspareunia, infertility, or persistent non-cyclical pain.

What to define early

Symptom pattern, impact on function, desire for fertility, prior treatment exposure, and whether deep disease or organ involvement is plausible.

What often gets missed

Heavy bleeding and iron-risk, bowel and bladder patterning, sex-related pain, and the distinction between cyclical pain and persistent pelvic pain.

What improves decision quality

Explicitly naming the treatment goal: symptom suppression, diagnosis clarification, disease mapping, fertility planning, or management of treatment failure.

Clinical position

Endometriosis management is goal-specific and preference-sensitive. Combined hormonal contraceptives and progestogens remain standard early options for pain suppression, but the presence of infertility, possible deep disease, endometrioma, or persistent pain after prior treatment changes the value of further empirical therapy.

Assessment elements that change the pathway

Cycle-linked versus constant symptoms. GI, urinary, and deep dyspareunia features suggesting deeper disease. Bleeding burden, dizziness, fatigue, and likely iron deficiency. Prior hormonal trials, side-effect history, and prior surgery. Immediate versus future fertility priorities.

Questions that sharpen the consult

What is the main symptom the patient most wants improved? Is the next step meant to suppress symptoms, obtain diagnosis, or move fertility planning forward? Are there symptoms that warrant specialist imaging or specialist service review now? What is the lowest-burden option that still has a reasonable chance of helping?

When the first consult should already be framed as more than routine pelvic pain care

Cyclical bowel symptoms, urinary symptoms, or deep dyspareunia may indicate disease complexity that changes imaging and referral needs. Persistent high-impact pain despite prior empirical treatment should not be treated as simple non-adherence or insufficient resilience. Fertility intent should be asked early because it changes the usefulness of suppressive therapy.

Module 2

Initial Medical Management

First-line management usually combines symptom relief with a reversible hormonal option when appropriate. The objective is to reduce pain and cyclical burden while preserving the ability to review response and escalate thoughtfully if needed.

Analgesia

Simple analgesia and anti-inflammatory strategies may provide partial relief, but repeated rescue use without adequate function should trigger review rather than indefinite recycling.

Combined hormonal contraception

Useful when the aim is cycle suppression and pain reduction, particularly when contraception is also desired and there are no contraindications.

Progestogen-based strategies

Tablets, LNG-IUS, implant, or injectable options may fit when estrogen is not ideal, tolerability is better, or a longer-acting approach is preferred.

Guardrail

Hormonal treatment is usually offered to reduce pain, not because it resolves every driver of pelvic pain. Partial response, non-response, or poor tolerability should not be framed as treatment failure in the patient. It may simply mean the dominant pain driver is different, the disease is more complex, or fertility priorities require a different pathway.

When first-line medical treatment is a strong fit

Pain is clearly cyclical and fertility is not the immediate priority. The patient wants a reversible option before considering surgery. There is no strong suggestion of bowel, bladder, or ureter involvement requiring urgent specialist framing. There is capacity to assess response against agreed outcomes.

When not to linger too long in empirical medical management

Prior hormonal trials have been adequate and poorly tolerated or ineffective. Persistent high-impact pain is continuing without a clear plan for next steps. Deep disease is suspected. Pregnancy is now the priority.

Where GnRH agonists or antagonists fit

These are generally later-line or specialist-framed options when simpler hormonal approaches are insufficient. They require clearer discussion of adverse effects, add-back strategies, time horizons, and what the treatment is meant to buy clinically. If the patient’s real question is diagnosis clarification or surgical candidacy, stronger suppression should not automatically replace that discussion.

Module 3

Imaging, Diagnosis, and Referral

Imaging and referral should not be treated as optional admin steps when the symptom pattern suggests complexity. NICE recommends specialist referral for suspected or confirmed endometrioma, deep endometriosis including bowel, bladder or ureter involvement, and extra-pelvic disease.

Ultrasound and MRI

Specialist transvaginal ultrasound or pelvic MRI may help diagnose and define the extent of deep disease when interpreted by clinicians with appropriate expertise.

Laparoscopy still matters

Consider laparoscopy for diagnosis even when ultrasound or MRI are normal if clinical suspicion remains meaningful and diagnostic clarification would change management.

Referral threshold

Bowel, bladder, ureter, extra-pelvic disease, or larger endometrioma features justify earlier specialist service framing rather than prolonged empirical cycling.

Clinical position

Normal imaging does not exclude clinically relevant endometriosis. A negative scan should not end the conversation when symptom burden remains high and management decisions still hinge on diagnostic certainty, disease mapping, or surgical planning.

Signals to escalate imaging or referral

Cyclical painful bowel movements, rectal symptoms, or bowel-pattern pain. Urinary pain, haematuria with menses, or concern for ureteric involvement. Deep dyspareunia with suspicion of posterior compartment disease. Endometrioma or suspected deep infiltrating disease on prior imaging. Persistent symptoms after reasonable empirical management.

Practical referral questions

Does this patient need a specialist endometriosis service rather than general gynecology follow-up alone? Would specialist imaging change the surgical discussion or risk assessment? Is the patient being kept in repeated medical trials because the care pathway is uncertain rather than because the treatment is clearly appropriate?

Why explicit referral criteria improve patient trust

Patients often tolerate uncertainty better when they understand what symptom or imaging features trigger specialist review. It prevents prolonged empirical management from feeling like a dead end. It also reduces the risk that high-impact bowel or urinary symptoms are minimized as “typical endo” without adequate assessment.

Module 4

Surgical Management and Follow-Up

Surgical management should be presented in terms of indication, expected gain, and postoperative plan. Excision or ablation may reduce pain for selected patients, but recurrence, persistent pain, and follow-up needs remain clinically important.

Clarify indication

Diagnosis, pain reduction, endometrioma management, deep disease treatment, or a fertility-linked reason.

Define expected benefit

Which symptom or anatomical problem is surgery expected to improve, and which drivers may remain?

Match the team

Deep disease involving bowel, bladder, or ureter needs the correct specialist service and operative planning.

Plan prevention and review

Consider postoperative hormonal treatment for secondary prevention when fertility is not the immediate objective.

Guardrail

Surgery is a management tool, not a blanket guarantee of cure

Overpromising pain resolution creates avoidable harm. Patients need honest discussion about the chance of partial response, symptom recurrence, and the role of postoperative care.

When surgical discussion is more justified

Persistent significant pain despite adequate medical management. Need for diagnostic clarification that would meaningfully alter management. Deep disease or endometrioma features needing specialist operative review. Selected fertility-linked contexts where surgery is being weighed carefully against reserve and access considerations.

Postoperative points to keep visible

Hormone suppression after surgery may reduce recurrence risk when conception is not currently desired. Persistent pain after surgery should reopen pain phenotype and multidisciplinary support review rather than trigger purely structural thinking. Follow-up is particularly relevant for deep disease and larger endometriomas.

Where hysterectomy fits clinically

Hysterectomy is not a first-line answer for typical endometriosis pain. It may become relevant in selected patients, especially when fertility is not desired and other pathology such as adenomyosis or severe uterine bleeding is part of the burden. It still requires careful counseling because it does not guarantee resolution of all pelvic pain drivers.

Module 5

Fertility-Priority Pathways

Once fertility is the priority, the question changes from “How do we suppress symptoms?” to “What gets this patient closest to pregnancy while respecting symptom burden, ovarian reserve, anatomy, time, and prior treatment exposure?”

Suppressive therapy is not a fertility treatment

Hormonal suppression is not used to improve spontaneous conception while actively trying to conceive, even though it may still have been appropriate earlier for symptom control.

Surgery requires reserve-aware thinking

Endometrioma surgery may reduce ovarian reserve, so pre-ART surgery should be justified by pain, access, anatomy, or individualized reproductive reasoning rather than habit alone.

ART may be the more logical step

In some contexts, assisted reproduction is more clinically coherent than another cycle of suppression or another surgery, especially when other infertility factors coexist.

Clinical position

Fertility-priority care should be built around time and reserve, not around default escalation habits. The patient’s age, history, prior surgeries, endometrioma characteristics, tubal factors, semen factors, and access to fertility care often matter more than the instinct to keep intensifying symptom-directed suppression.

Questions that sharpen fertility-pathway decisions

Is pregnancy being attempted now or in the near term? Would another suppressive trial delay a more appropriate fertility step? Would surgery meaningfully improve pain, access to follicles, or anatomy, or mainly add reserve risk? Is the patient better served by fertility referral and shared planning now?

Common clinician traps

Continuing hormonal cycling because it is familiar even when conception is now the priority. Assuming surgery automatically improves reproductive outcome. Ignoring the time cost of serial low-yield treatment changes. Separating symptom burden and fertility planning when both need to be discussed in the same consult.

What to communicate clearly to patients in fertility-priority care

The best symptom-control option is not always the best fertility option. Surgery, expectant management, and ART each have contexts where they are more or less coherent. The key is not to promise certainty, but to explain why one route fits the current reproductive timeline better than another.

Module 6

Persistent Pain and Multidisciplinary Care

Persistent pain after first-line therapy or surgery should trigger phenotype review, not only stronger escalation. NICE emphasizes access to multidisciplinary pain management, and broader care remains clinically appropriate when quality of life is substantially affected.

Persistent pelvic pain phenotype

Consider whether pelvic floor dysfunction, centralized pain, bowel overlap, bladder symptoms, musculoskeletal factors, or sexual pain are sustaining the burden.

Multidisciplinary pain services

Pain management input can coexist with gynecology treatment and may be especially useful when repeated medical or surgical steps are not restoring function.

Supportive care language

Pelvic health, movement support, psychology, and nutritional care should be framed as quality-of-life and function supports rather than substitutes for disease recognition.

Guardrail

Supportive care should not be used to minimize structural disease, but it should not be withheld because evidence is imperfect. Guideline groups remain cautious about specific non-pharmacological modalities because of weak or heterogeneous evidence. That still leaves room for multidisciplinary care when it is aligned with symptom pattern, function, and patient goals.

When the persistent-pain frame is useful

Pain remains disabling after adequate empirical hormonal treatment. Symptoms persist or recur after surgery. Pelvic floor, bowel, bladder, or sexual pain drivers appear prominent. The patient is stuck in serial treatment changes without improved function.

Patient tools

Useful linked patient tools

Pain flare guide for home-support language and escalation awareness. Movement guide when fear of movement and deconditioning are part of the burden. Nutrition course when GI symptoms, food stress, or bleeding-related fatigue coexist.

Module 7

Practical Sequencing and Review

The strongest clinical plans are explicit about sequence, stopping rules, review points, and onward referral triggers. Patients cope better when the pathway is visible.

Define the goal

Pain suppression, bleeding control, diagnostic clarification, fertility progression, or persistent-pain support.

Offer the lowest-burden reasonable step

Usually analgesia plus an appropriate hormonal option unless fertility or complexity changes that logic.

State the escalation criteria

Deep disease features, inadequate response, poor tolerability, persistent dysfunction, or fertility-priority change.

Review against outcomes that matter

Pain days, function, bleeding burden, sleep, work or study participation, and patient-reported meaningful benefit.

What a coherent management note often makes explicit

The dominant symptom pattern. The current fertility position. The treatment being trialed and why. How success or failure will be judged. What would trigger imaging, referral, surgery discussion, or pain-service involvement.

Signals that the plan needs re-framing

The same category of treatment is being retried without a new rationale. The patient remains highly impaired despite “technically treated” disease. Fertility intent has changed but the management plan has not. Bowel, bladder, or deep-disease features are present without specialist escalation.

InsideHer reminder

The goal is not to offer every option. It is to offer the next option that is most coherent. Visible logic, shared decision-making, and planned review usually improve care quality more than reflex escalation alone.

Printable tool

Printable shortcut: clinician decision aid

Use the printable Clinician Endometriosis Treatment Decision Aid for a one-page summary of pathway selection, referral logic, and review triggers.

Need the wider endometriosis library?

This clinician course is one section of the full endometriosis course library. Move back into the course home any time to find the patient and clinician versions of every symptom pathway.

Back to all courses

InsideHer is an educational companion, not a substitute for medical care. Back to courses →